Pfizer

The new at-home COVID treatment is currently available in limited quantities to states and territories. Some states will get as few as 120 courses of treatment at first.

The research finds that the medicine, called Paxlovid, was effective in preventing hospitalization and death when taken by people with mild to moderate illness within a few days of symptoms.

Pfizer researchers looking for a drug to treat SARS found clues that gave the company a head start in its quest for a pill to treat COVID-19, including the omicron variant.

The Food and Drug Administration is expected to announce later this week that it is authorizing boosters for people 18 or older, even if they aren't at risk for severe disease.

Central Ohio clinics and hospitals have begun offering the Pfizer COVID-19 vaccine for kids aged 5 to 11.

The CDC approved Pfizer's COVID-19 vaccine for kids aged five to 11 years old on Tuesday, and health centers are preparing to make shots available to the 125,000 kids in Franklin County now eligible.

After some debate, a group of scientists advising the FDA concluded that the vaccine's benefits outweigh its risks for young children.

The companies studied a 10 microgram vaccine dose in children 5 to 11, a third of the dose used for adults, to minimize side effects and because it still prompts a strong immune response.

"With new cases in children in the U.S. continuing to be at a high level, this submission is an important step in our ongoing effort against #COVID19," the pharmaceutical giant said.

Pfizer and BioNTech say they plan to submit a formal request for emergency use authorization of their vaccine in young children "in the coming weeks."